@clerkstep31
Active 7 hours, 52 minutes ago
However, the differences observed were minor, and we conclude that there is currently insufficient evidence to consider location and/or molecular effect of pathogenic variants to assist with clinical management of TP53 carriers. Larger studies are necessary to confirm the correlations suggested by our analysis.Breast cancer remains one of the […] View
